| Literature DB >> 27082633 |
Simone Belluco1,2, Marzia Mancin1, Daniele Conficoni2, Giulia Simonato2, Mario Pietrobelli2, Antonia Ricci1.
Abstract
BACKGROUND: Toxoplasma gondii is one of the most widespread parasites in humans and can cause severe illness in immunocompromised individuals. However, its role in healthy people is probably under-appreciated. The complex epidemiology of this protozoan recognizes several infection routes but consumption of contaminated food is likely to be the predominant one. Among food, consumption of raw and undercooked meat is a relevant route of transmission, but the role of different meat producing animal species and meats thereof is controversial.Entities:
Mesh:
Year: 2016 PMID: 27082633 PMCID: PMC4833317 DOI: 10.1371/journal.pone.0153856
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flowchart describing the selection of relevant studies.
*papers added during the last update ** papers added through cross checking.
Characteristics of 91 studies reporting prevalence for T. gondii gondii that were tested as sources of heterogeneity.
| Cattle | Pigs | Sheep | ||||
|---|---|---|---|---|---|---|
| K | N | K | N | K | N | |
| 21 | 3785 | 41 | 10894 | 29 | 4150 | |
| -Africa | - | - | 2 | 100 | 4 | 351 |
| -Asia | 3 | 170 | 2 | 439 | 8 | 376 |
| -Central America | 3 | 100 | 1 | 48 | - | - |
| -Europe | 4 | 651 | 14 | 3074 | 8 | 1061 |
| -North America | 3 | 2429 | 7 | 6318 | 2 | 469 |
| -Oceania | 1 | 80 | 1 | 30 | 2 | 64 |
| -South America | 7 | 355 | 14 | 885 | 5 | 1829 |
| -<12 months | - | - | - | - | 8 | 991 |
| ->12 months | - | - | - | - | 9 | 543 |
| -NS | - | - | - | - | 12 | 2616 |
| -Conventional | - | - | 2 | 397 | - | - |
| -Organic | - | - | 4 | 86 | - | - |
| -Small farms | - | - | 2 | 433 | - | - |
| -NS | - | - | 33 | 9978 | - | - |
| -Bioassay in cats | 2 | 2369 | 1 | 2094 | - | - |
| -Bioassay in mice | 12 | 600 | 28 | 5695 | 11 | 2137 |
| -PCR | 7 | 816 | 12 | 3105 | 16 | 1913 |
| -Microscopy | - | - | - | - | 2 | 100 |
| -Single | 14 | 3095 | 21 | 4670 | 17 | 2123 |
| -Pooled within animal | 7 | 690 | 12 | 5321 | 12 | 2027 |
| -Meat products | - | - | 5 | 336 | - | - |
| -Cured meat products | - | - | 3 | 567 | - | - |
| -Slaughterhouse | 9 | 1315 | 21 | 7094 | 21 | 3686 |
| -Retail | 9 | 2332 | 18 | 3739 | 7 | 414 |
| -NS | 3 | 138 | 2 | 61 | 1 | 50 |
| -No | - | - | 35 | 6808 | 22 | 1946 |
| -Yes | - | - | 6 | 4086 | 7 | 2204 |
K = number of studies (note that some individual published papers contained more than one study), N = number of samples, NS = non specified in the primary study.
General information about eligible studies reporting data for cattle.
| ID | Reference | Country | Geographic area | Sampling location | Analytical technique | Technique specifications | Sampled organ |
|---|---|---|---|---|---|---|---|
| 1 | Costa Rica | Central America | Retail | Bio mice | Feed | Liver | |
| 2 | Costa Rica | Central America | Retail | Bio mice | Feed | Heart | |
| 3 | Costa Rica | Central America | Retail | Bio mice | Feed | Muscle | |
| 4 | Iran | Asia | NS | PCR | Nested | Brain/Liver/Muscle | |
| 5 | Switzerland | Europe | Slaughterhouse | PCR | Real-T PCR | Diaphragm | |
| 6 | Colombia | South America | Retail | PCR | Nested | Muscle | |
| 7 | Czech Republic | Europe | NS | Bio mice | IP | Brain/Diaphragm | |
| 8 | US | North America | Slaughterhouse | Bio cats | Feed | Heart/Diaphragm | |
| 9 | US | North America | Retail | Bio cats | Feed | Muscle | |
| 10 | Turkey | Asia | Slaughterhouse | PCR | Nested | Brain/Muscle | |
| 11 | Portugal | Europe | Slaughterhouse | Bio mice | IP | Brain/Heart/Diaphragm | |
| 12 | US | North America | Slaughterhouse | Bio mice | IP | Diaphragm | |
| 13 | New Zealand | Oceania | Slaughterhouse | Bio mice | IP | Diaphragm | |
| 14 | Brazil | South America | Retail | Bio mice | IP | Muscle | |
| 15 | Brazil | South America | Retail | Bio mice | IP | Liver | |
| 16 | Brazil | South America | Retail | Bio mice | IP | Brain | |
| 17 | Brazil | South America | NS | Bio mice | IP | Muscle | |
| 18 | The Netherlands | Europe | Slaughterhouse | PCR | MC-PCR | Heart | |
| 19 | Brazil | South America | NS | Bio mice | IP | Diaphragm | |
| 20 | Iran | Asia | Slaughterhouse/ Retail | PCR | PCR | Tongue/Heart/Muscle | |
| 21 | Brazil | South America | Slaughterhouse | PCR | Nested | Brain/Heart |
Bio mice = Bioassays in mice, IP = intra-peritoneal, MC-PCR = magnetic capture PCR, NS = not specified in the primary study.
General information about eligible studies reporting data for sheep.
| ID | References | Country | Geographic area | Animal age | Analytical technique | Sampled organ | |
|---|---|---|---|---|---|---|---|
| 1 | Iran | Asia | >12 | PCR | Nested | Brain/Liver/Muscle | |
| 2 | Iran | Asia | <12 | PCR | Nested | Brain/Liver/Muscle | |
| 3 | Iran | Asia | <12 | PCR | Nested | Brain/Liver/Muscle | |
| 4 | Switzerland | Europe | <12 | PCR | Real Time PCR | Diaphragm | |
| 5 | Switzerland | Europe | >12 | PCR | Real Time PCR | Diaphragm | |
| 6 | Morocco | Africa | NS | Bio mice | Feed/IP | Brain | |
| 7 | Tunisia | Africa | >12 | PCR | PCR | Heart | |
| 8 | Brazil | South America | NS | Bio mice | NS | Heart/Diaphragm | |
| 9 | US | North America | <12 | Bio mice | Feed | Heart | |
| 10 | France | Europe | >12 | Bio mice | IP | Heart | |
| 11 | Turkey | Asia | NS | PCR | Nested | Brain/Muscle | |
| 12 | Turkey | Asia | NS | PCR | Nested | Brain | |
| 13 | Tunisia | Africa | NS | PCR | Nested | Heart | |
| 14 | Switzerland | Europe | NS | PCR | Real Time PCR | Brain/Muscle | |
| 15 | France | Europe | <12 | Bio mice | IP | Heart | |
| 16 | France | Europe | >12 | Bio mice | IP | Heart | |
| 17 | Ireland | Europe | NS | PCR | Nested | Diaphragm | |
| 18 | US | North America | NS | Bio mice | IP | Diaphragm | |
| 19 | New Zealand | Oceania | >12 | Bio mice | IP | Brain/Diaphragm/Muscle | |
| 20 | Brazil | South America | >12 | Bio mice | IP | Muscle | |
| 21 | Tunisia | Africa | >12 | PCR | Nested | Heart | |
| 22 | Brazil | South America | NS | PCR | Nested | Brain | |
| 23 | The Netherlands | Europe | NS | PCR | MC-PCR | Heart | |
| 24 | Brazil | South America | NS | Bio mice | NS | Heart/Brain/Diaphragm | |
| 25 | Iran | Asia | <12 | PCR | PCR | Tongue/Heart/Muscle | |
| 26 | Australia | Oceania | <12 | Bio mice | IP | Muscle | |
| 27 | Turkey | Asia | <12 | Micro | NA | Brain/Diaphragm/Muscle | |
| 28 | Turkey | Asia | >12 | Micro | NA | Brain/Diaphragm/Muscle | |
| 29 | Brazil | South America | NS | PCR | PCR | Brain/Diaphragm | |
Bio mice = Bioassays in mice, IP = intra-peritoneal, SC = subcutaneous, MC-PCR = magnetic capture PCR, NS = not specified in the primary study, NA = Not Appliable,
*studies that performed a serological screening.
Summary of heterogeneity measures and Likelihood Ratio Test for each moderator tested in studies describing T. gondii prevalence in cattle.
| T2 (95%CI) | I2 (95%CI) | LRT p-value | R2 | |
|---|---|---|---|---|
| 0.0215 (0.0113–0.0620) | 91.6 (85.3–96.9) | |||
| 0.0150 (0.0066–0.0589) | 84.8 (71–95.6) | 0.032 | 61.86 | |
| 0.0206 (0.0106–0.0613) | 90.76 (83.48–96.69) | 0.16 | 10.86 | |
| 0.0166 (0.0084–0.0601) | 85.56 (74.91–95.54) | 0.063 | 38.37 | |
| 0.0232 (0.0121–0.0674) | 91.33 (84.58–96.84) | 0.89 | 0 | |
| 0.0213 (0.0107–0.0626) | 88.52 (79.52–95.78) | 0.22 | 13.74 |
LRT = Likelihood Ratio Test
*statistically significant results.
Fig 2Cumulative meta-analysis on cattle studies based on decreasing sample size.
T+ = positive samples, N = number of samples.
Summary of the output of univariable meta-regression in cattle or meat thereof for each category within moderators.
| Moderator | K | N | Β | SE | Prevalence (95%CI) | |
|---|---|---|---|---|---|---|
| 3 | 170 | Asia | 0.2776 | 0.0806 | 0.060 (0.002–0.166) | |
| 3 | 100 | Central America | 0.4263 | 0.0969 | 0.159 (0.040–0.328) | |
| 4 | 655 | Europe | 0.1933 | 0.0661 | 0.022 (0.000–0.087) | |
| 3 | 2429 | North America | 0.0592 | 0.0744 | 0.000 (0.000–0.026) | |
| 1 | 80 | Oceania | 0.0557 | 0.1347 | 0.000 (0.000–0.085) | |
| 7 | 355 | South America | 0.1988 | 0.0558 | 0.024 (0.000–0.078) | |
| 21 | 3785 | 0.0027 | 0.0021 | |||
| 2 | 2369 | Bio cats | 0.0203 | 0.0926 | 0.000 (0.000–0.025) | |
| 12 | 600 | Bio mice | 0.19836 | 0.0447 | 0.024 (0.001–0.065) | |
| 7 | 820 | PCR | 0.2672 | 0.0536 | 0.055 (0.012–0.0119) | |
| 14 | 3095 | Single | 0.2087 | 0.0460 | 0.032 (0.004–0.076) | |
| 7 | 690 | Pooled within | 0.1973 | 0.0616 | 0.027 (0.000–0.087) | |
| 9 | 1315 | Slaughterhouse | 0.1499 | 0.0490 | 0.011 (0.000–0.048) | |
| 9 | 2332 | Retail | 0.2792 | 0.0611 | 0.065 (0.014–0.142) | |
| 3 | 138 | NS | 0.2256 | 0.0966 | 0.039 (0.000–0.154) |
N = number of samples, K = number of studies, SE = Standard error, Bio = Bioassay,
*statistically significant results.
General information about eligible studies reporting data for pigs.
| ID | Reference | Country | Geographic area | Farm | Serological screening | Analytical technique | Sampled organ | |
|---|---|---|---|---|---|---|---|---|
| 1 | UK | Europe | NS | NA | PCR | PCR | Meat products (Mixed) | |
| 2 | Italy | Europe | O | NA | PCR | Nested | Heart | |
| 3 | Spain | Europe | NS | NA | Bio mice | IP | Muscle | |
| 4 | Spain | Europe | NS | NA | Bio mice | IP | Cured Ham | |
| 5 | Brazil | South America | NS | NA | PCR | PCR | Tongue/Diaphragm | |
| 6 | Switzerland | Europe | NS | NA | PCR | Real-T PCR | Diaphragm | |
| 7 | Brazil | South America | O | NA | Bio mice | SC | Brain/Tongue | |
| 8 | Brazil | South America | SF | Sero + | Bio mice | IP | Brain/heart | |
| 9 | Czech Republic | Europe | NS | NA | Bio mice | IP | Brain/Diaphragm | |
| 10 | Brazil | South America | NS | Sero + | Bio mice | IP | Heart | |
| 11 | Brazil | South America | NS | NA | Bio mice | Inoculation | Sausages | |
| 12 | US | North America | NS | NA | Bio mice | SC | Heart | |
| 13 | US | North America | NS | Bio cats | Bio cats | Feed | Muscle | |
| 14 | US | North America | O | Na | Bio mice | SC | Heart | |
| 15 | Portugal | Europe | NS | Sero + | PCR | Nested | Brain/Diaphragm | |
| 16 | Portugal | Europe | C | NA | Bio mice | IP | Brain/Heart/Diaphragm | |
| 17 | Brazil | South America | O | NA | Bio mice | IP | Brain | |
| 18 | Brazil | South America | NS | NA | Bio mice | Inoculation | Heart | |
| 19 | Brazil | South America | NS | NA | Bio mice | Inoculation | Brain | |
| 20 | Brazil | South America | NS | Sero + | Bio mice | SC | Brain/Heart/Muscle | |
| 21 | Canada | North America | NS | NA | Bio mice | SC | Heart/Diapraghm | |
| 22 | Mexico | Central America | NS | NA | Bio mice | SC | Muscle | |
| 23 | Spain | Europe | NS | NA | PCR | MC-PCR | Serrano ham | |
| 24 | Ireland | Europe | NS | NA | PCR | Nested | Diaphragm | |
| 25 | US | North America | NS | NA | Bio mice | IP | Diaphragm | |
| 26 | Brazil | South America | NS | NA | Bio mice | IP | Muscle | |
| 27 | Brazil | South America | NS | NA | Bio mice | IP | Sausages | |
| 28 | Brazil | South America | NS | NA | Bio mice | IP | Muscle | |
| 29 | Brazil | South America | NS | NA | PCR | SC | Sausages | |
| 30 | Brazil | South America | NS | NA | Bio mice | IP | Muscle | |
| 31 | Brazil | North America | NS | NA | Bio mice | IP | Brain | |
| 32 | Australia | Oceania | NS | NA | Bio mice | IP | Muscle | |
| 33 | Brazil | North America | NS | NA | PCR | Nested | Heart | |
| 34 | Egypt | Africa | NS | NA | Bio mice | IP | Diaphragm/Muscle | |
| 35 | Egypt | Africa | NS | NA | Bio mice | IP | Sausages and Mortadella | |
| 36 | Portugal | Europe | SF | Sero + | Bio mice | SC | Brain/Heart | |
| 37 | Slovakia | Europe | NS | Sero + | PCR | Nested | Brain/Heart | |
| 38 | Czech Republic | Europe | C | NA | Bio mice | IP | Brain/Diaphragm | |
| 39 | China | Asia | NS | NA | PCR | Real-T PCR | Muscle | |
| 40 | China | Asia | NS | NA | Bio mice | IP | Brain | |
| 41 | UK | Europe | NS | NA | PCR | Nested | Sausages dried/ cured | |
Bio mice = Bioassays in mice, IP = intra-peritoneal, SC = subcutaneous, MC-PCR = magnetic capture PCR, NS = not specified in the primary study, NA = Not Appliable, Sero+ = seropositive.
Summary of heterogeneity measures and Likelihood Ratio Test for each moderator tested in studies describing T. gondii prevalence in pigs.
| T2 (95%CI) | I2 (95%CI) | LRT p-value | R2 | |
|---|---|---|---|---|
| 0.0534 (0.0346–0.0931) | 98.1 (97.1–98.9) | |||
| 0.0499 (0.0313–0.0930) | 97.8 (96.6–98.8) | 0.17 | 22.79 | |
| 0.0365 (0.0223–0.0629) | 97.2 (95.5–98.4) | 0.0004 | 37.31 | |
| 0.0545 0.0351 0.0952 | 98 (97–98.9) | 0.52 | 0.65 | |
| 0.0524 (0.0335–0.0930) | 97.4 (96–98.5) | 0.24 | 7.86 | |
| 0.0547 (0.0348–0.0971) | 97.8 (96.6–98.7) | 0.48 | 6.32 | |
| 0.0550 (0.0353 0.0970) | 98 (96.8–98.8) | 0.58 | 2.64 | |
| 0.0529 (0.0341–0.0934) | 97.8 (96.6–98.7) | 0.25 | 3.9 |
LRT = Likelihood Ratio Test
*statistically significant results.
Fig 3Cumulative meta-analysis on pig studies based on decreasing sample size.
T+ = positive samples, N = number of samples.
Summary of the output of univariable meta-regression analysis in pigs for each category within moderators.
| Moderator | K | N | β | SE | Prevalence (95%CI) | |
|---|---|---|---|---|---|---|
| 2 | 100 | Africa | 0.1201 | 0.1657 | 0.005 (0.000–0.178) | |
| 2 | 493 | Asia | 0.4430 | 0.1660 | 0.176 (0.005–0.483) | |
| 1 | 48 | Central America | 0.1734 | 0.2347 | 0.020 (0.000–0.347) | |
| 14 | 3074 | Europe | 0.3159 | 0.0622 | 0.087 (0.027–0.172) | |
| 7 | 6318 | North America | 0.3427 | 0.0868 | 0.104 (0.019–0.235) | |
| 1 | 30 | Oceania | 0.2187 | 0.2411 | 0.037 (0.000–0.404) | |
| 14 | 885 | South America | 0.4974 | 0.0643 | 0.221 (0.123–0.337) | |
| 2 | 397 | Conventional | 0.1253 | 0.1383 | 0.006 (0.000–0.141) | |
| 4 | 86 | Organic | 0.8189 | 0.1106 | 0.534 (0.316–0.746) | |
| 2 | 433 | Small Farms | 0.3558 | 0.1381 | 0.112 (0.000–0.140) | |
| 33 | 9978 | NS | 0.3386 | 0.0355 | 0.101 (0.061–0.149) | |
| 41 | 10894 | 0.0020 | 0.0026 | |||
| 1 | 2094 | Bio cats | 0.0598 | 0.2292 | 0.000 (0.000–0.231) | |
| 28 | 5695 | Bio mice | 0.3563 | 0.0459 | 0.113 (0.059–0.179) | |
| 12 | 3105 | PCR | 0.4314 | 0.0681 | 0.167 (0.076–0.281) | |
| 21 | 4670 | Single | 0.4080 | 0.0541 | 0.149 (0.079–0.236) | |
| 12 | 5321 | Pooled within | 0.3475 | 0.0694 | 0.107 (0.034–0.209) | |
| 5 | 336 | Meat products | 0.3935 | 0.1109 | 0.139 (0.020–0.325) | |
| 3 | 567 | Cured meat products | 0.1881 | 0.1404 | 0.025 (0.000–0.0193) | |
| 21 | 7094 | Slaughterhouse | 0.3649 | 0.0531 | 0.119 (0.057–0.197) | |
| 18 | 3739 | Retail | 0.3604 | 0.0585 | 0.116 (0.049–0.202) | |
| 2 | 61 | NS | 0.5496 | 0.1789 | 0.267 (0.029–0.616) | |
| 35 | 6808 | No | 0.3911 | 0.0417 | 0.137 (0.083–0.200) | |
| 6 | 4086 | Yes | 0.2805 | 0.0889 | 0.067 (0.003–0.186) |
K = number of studies, N = number of samples, SE = Standard error,
*statistically significant results.
Summary of heterogeneity measures and Likelihood Ratio Test for each moderator tested in studies describing Toxoplasma prevalence in sheep.
| T2 (95%CI) | I2 (95%CI) | LRT p-value | R2 | |
|---|---|---|---|---|
| 0.0513 (0.0309–0.0988) | 96.6 (94.4–98.2) | - | - | |
| 0.046 (0.0241–0.0887) | 95.6 (92.5–97.8) | 0.055 | 33.8 | |
| 0.0470 (0.0279–0.0956) | 96.1 (93.6–98.1) | 0.13 | 15.9 | |
| 0.0532 (0.0319–0.1040) | 96.7 (94.6–98.3) | 0.88 | 0.2 | |
| 0.0470 (0.0278–0.0947) | 96.2 (93.7–98.1) | 0.11 | 15.9 | |
| 0.0458 (0.0269–0.0868) | 96 (93.3–97.8) | 0.03 | 14.1 | |
| 0.0536 (0.0316–0.1044) | 96.8 (94.7–98.3) | 0.54 | 3.48 | |
| 0.0529 (0.0316–0.1032) | 96.6 (94.3–98.2) | 0.61 | 1 |
LRT = Likelihood Ratio Test
*statistically significant results.
Fig 4Cumulative meta-analysis on sheep studies based on decreasing sample size.
T+ = positive samples, N = number of samples.
Summary of the output of univariable meta-regression analysis in sheep for each category within moderators.
| Moderator | K | N | β | SE | Prevalence (95%CI) | |
|---|---|---|---|---|---|---|
| 4 | 351 | Africa | 0.4752 | 0.1074 | 0.203 (0.059–0.399) | |
| 8 | 376 | Asia | 0.5525 | 0.0786 | 0.271 (0.143–0.420) | |
| 8 | 1061 | Europe | 0.3297 | 0.0750 | 0.096 (0.023–0.204) | |
| 2 | 469 | North America | 0.4003 | 0.1489 | 0.144 (0.003–0.405) | |
| 2 | 64 | Oceania | 0.5295 | 0.1586 | 0.250 (0.038–0.556) | |
| 5 | 1829 | South America | 0.1946 | 0.0964 | 0.028 (0.000–0.132) | |
| 8 | 991 | <12 months | 0.4125 | 0.0807 | 0.153 (0.054–0.287) | |
| 9 | 543 | >12 months | 0.5171 | 0.0768 | 0.239 (0.120–0.381) | |
| 12 | 2616 | NS | 0.3177 | 0.0643 | 0.089 (0.027–0.177) | |
| 30 | 4150 | 0.0004 | 0.0031 | |||
| 11 | 2137 | Bio mice | 0.4020 | 0.0685 | 0.146 (0.061–0.256) | |
| 16 | 1913 | PCR | 0.3662 | 0.565 | 0.120 (0.055–0.204) | |
| 2 | 100 | Micro | 0.7147 | 0.1616 | 0.428 (0.143–0.741) | |
| 17 | 2123 | Single | 0.3287 | 0.0540 | 0.096 (0.039–0.170) | |
| 12 | 2027 | Pooled within | 0.5116 | 0.0651 | 0.234 (0.133–0.353) | |
| 21 | 3686 | Slaughterhouse | 0.4289 | 0.0510 | 0.166 (0.096–0.249) | |
| 7 | 414 | Retail | 0.3084 | 0.1004 | 0.083 (0.004–0.228) | |
| 1 | 50 | Slaughter/retail | 0.2419 | 0.3934 | 0.139 (0.000–0.584) | |
| 22 | 1946 | No | 0.4163 | 0.0514 | 0.156 (0.088–0.239) | |
| 7 | 2155 | Yes | 0.3666 | 0.0886 | 0.120 (0.027–0.259) |
K = number of studies, N = number of samples, SE = Standard Error, Bio = Bioassays,
*statistically significant results.